Long-Acting Injectable HIV Therapy Outcomes Among Persons With HIV Who Have Adherence Challenges to Oral Antiretroviral Therapy
Clinical Infectious Diseases · 2025
DOI: 10.1093/cid/ciaf120 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Clinical Infectious Diseases, 2025. Verfasst von Elizabeth Hastie und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Division of Infectious Diseases and Global Public Health, University of California-San Diego, San Diego, California, USA. Hauptthemen laut MEDLINE: HIV Infections, Rilpivirine, Anti-HIV Agents, Medication Adherence. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIAID NIH HHS.
Abstract (Originalsprache)
Long-acting injectable cabotegravir/rilpivirine (LAI-CAB/RPV) may improve outcomes among persons with human immunodeficiency virus (PWH) with adherence difficulties to oral therapy. In this real-world observational study, over 85% of PWH remained on therapy and virally suppressed 48 weeks after initiating LAI-CAB/RPV. Providers should consider LAI therapy among PWH with adherence difficulties.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine, Division of Infectious Diseases and Global Public Health, University of California-San Diego, San Diego, California, USA.
- Department of Medicine, Division of Infectious Diseases and Global Public Health, Veterans Affairs-San Diego, San Diego, California, USA.
ORCID-Profile: Elizabeth Hastie
Förderung
- NIAID NIH HHS
Zitieren
APA
Hastie, E., Hill, L., Bamford, L., Karim, A., & Martin, T. C. S. (2025). Long-Acting Injectable HIV Therapy Outcomes Among Persons With HIV Who Have Adherence Challenges to Oral Antiretroviral Therapy. Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciaf120
Vancouver
Hastie E, Hill L, Bamford L, Karim A, Martin TCS. Long-Acting Injectable HIV Therapy Outcomes Among Persons With HIV Who Have Adherence Challenges to Oral Antiretroviral Therapy. Clinical Infectious Diseases. 2025. doi:10.1093/cid/ciaf120
BibTeX
@article{Hastie2025,
author = {Hastie, Elizabeth and Hill, Lucas and Bamford, Laura and Karim, Afsana and Martin, Thomas C S},
title = {Long-Acting Injectable HIV Therapy Outcomes Among Persons With HIV Who Have Adherence Challenges to Oral Antiretroviral Therapy},
journal = {Clinical Infectious Diseases},
year = {2025},
doi = {10.1093/cid/ciaf120}
}
EUVIMED